| Name | Title | Contact Details |
|---|
IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, IlluminOss System. This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants. The IlluminOss System utilizes a light-curable polymer, contained within an expandable balloon catheter to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of orthopedic bone stabilization. The company currently markets its products in the EU under a CE Mark for approved clinical applications through both a direct sales force and distribution networks. Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Flare Capital Partners, New Leaf Venture Partners, Tekla Capital, Life Sciences Partners, SR One, Longwood Fund, Excel Venture Management, Pappas Ventures, Mieza Capital and Slater Technology.
LensGen™ is an ophthalmic medical device company developing an accommodating intraocular lens (AIOL) based solution to treat presbyopia and/or cataracts.
Nevro`s Senza system is the only SCS system capable of delivering HF10™ therapy and providing pain relief without paresthesia.
PRIO Corporation is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MicroCal, LLC is a Northampton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.